Overview of Dr. Thompson
Dr. Meghan Thompson is an internist in Basking Ridge, NJ and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and Memorial Hospital for Cancer and allied Diseases. She received her medical degree from Ohio State University College of Medicine and has been in practice 0 years. She is one of 236 doctors at Memorial Sloan Kettering Cancer Center and one of 4 doctors at Memorial Hospital for Cancer and allied Diseases who specialize in Internal Medicine. She has more than 20 publications and over 500 citings.
Office
136 Mountain View Boulevard
Basking Ridge, NJ 07920
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2019 - 2022
- University of Pennsylvania Health SystemResidency, Internal Medicine, 2016 - 2019
- Ohio State University College of MedicineClass of 2016
- Princeton UniversityA.B., Economics, 2007 - 2011
Certifications & Licensure
- NJ State Medical License 2022 - 2025
- NY State Medical License 2020 - 2025
- PA State Medical License 2016 - 2019
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Navigating the changing landscape of BTK-targeted therapies for B cell lymphomas and chronic lymphocytic leukaemia.Michele D Stanchina, Skye Montoya, Alexey V Danilov, Jorge J Castillo, Alvaro J Alencar
Nature Reviews. Clinical Oncology. 2024-12-01 - Real-world incidence and prevention of tumor lysis syndrome in chronic lymphocytic leukemia treated with venetoclax.Yannis K Valtis, David Nemirovsky, Andriy Derkach, Saumya Sharan, Charlene Kabel
Blood Advances. 2024-11-26 - 1 citationsUniversal germline genetic testing in patients with hematologic malignancies using DNA isolated from nail clippings.Ozge Ceyhan-Birsoy, Elise Fiala, Satshil Rana, Margaret Sheehan, Jennifer Kennedy
Haematologica. 2024-10-01
Press Mentions
- How to Manage Venetoclax Resistance in Chronic Lymphocytic LeukemiaJune 23rd, 2021
- Triple Therapy for CLL Shows Promise in Phase 2 TrialSeptember 21st, 2020
- MSK Research Highlights, February 12, 2024February 13th, 2024
Research History
- Research AssistantCenter for Injury Research and Policy, The Research Institute at Nationwide Children's Hospital2011 - 2013
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: